000			02185ngm a2200457 a 4500
001			HST3471_1_2
003			UkLoHST
006			m c
007			cr|cna|||a||||
007			vz|czazum
008			131018s2013 enk|||||||||||s|||v|eng d
028	5	0	_a3471 _bHenry Stewart Talks
035			_a(UkLoHST)2583
040			_aUkLoHST _beng _cUkLoHST
100	1		_aKarron, Ruth A., _u(Johns Hopkins Bloomberg School of Public Health, USA) _4spk
245	1	0	_aRSV vaccine development _h[electronic resource] / _cRuth A. Karron.
246	3		_aRespiratory syncytial virus vaccine development
260			_aLondon : _bHenry Stewart Talks, _c2013.
300			_a1 online resource (1 streaming video file (34 min.) : _bcolor, sound).
490	1		_aRespiratory infection, _x2056-452X
500			_aAnimated audio-visual presentation with synchronized narration.
500			_aTitle from title frames.
505	0		_aContents: Many obstacles hinder RSV vaccine development -- Disease at extremes of age -- History of disease potentiation with formalin-inactivated RSV vaccine -- Various strategies for vaccine development -- RSV F subunit vaccine -- Maternal immunization -- Immunization of the elderly -- Live-attenuated and/or live-vectored vaccines -- Immunization of infants and children.
506			_aAccess restricted to subscribers.
538			_aMode of access: World Wide Web.
650		0	_aDrug development.
650		0	_aRespiratory syncytial virus.
650		0	_aVaccines.
650		2	_aRespiratory Syncytial Virus Infections _xepidemiology.
650		2	_aRespiratory Syncytial Virus Infections _ximmunology.
650		2	_aRespiratory Syncytial Virus Infections _xprevention & control.
650		2	_aRespiratory Syncytial Virus Vaccines _xpharmacology.
650		2	_aRespiratory Syncytial Virus Vaccines.
650		2	_aRespiratory Syncytial Virus, Human.
650		2	_aVaccination _xtrends.
650		2	_aVaccines, Attenuated.
650		2	_aViral Vaccines.
830		0	_aHenry Stewart talks. _pBiomedical & life sciences collection. _pRespiratory infection.
856	4	0	_uhttps://hstalks.com/bs/2583/
856	4	2	_uhttps://hstalks.com/bs/p/726/ _3Series
999			_c77186 _d77186